Pediatric regime of chemotherapy proves more effective for young adults
Acute lymphoblastic leukemia (ALL), usually found in pediatric patients, is far more rare and deadly in adolescent and adult patients. According to the National Marrow Donor Program, child ALL patients have a higher than 80 percent remission rate, while the recovery rate for adults stands at only 40 percent.
In current practice, pediatric and young adult ALL patients undergo different treatment regimes. Children aged 0-15 years are typically given more aggressive chemotherapy, while young adults, defined as people between 16 and 39 years of age, are treated with a round of chemotherapy followed by a bone marrow transplant. But a new study has revealed that it may be time to rethink this strategy, says Dr. Ron Ram of Tel Aviv University's Sackler Faculty of Medicine and the Davidoff Cancer Center at the Rabin Medical Center.
Dr. Ram and his fellow researchers have determined that a pediatric treatment regime for young adult patients with ALL improves their chance of long-term survival, and decreases the mortality rate itself by 40% all without the additional complications of a bone marrow transplant. Their findings have been published in the American Journal of Hematology.
Avoiding the transplant list
There are a number of reasons for the differing treatment regimes, including physical stress, psychological preparedness, and prevalence of the disease. Pediatric oncologists, who see dozens of cases of ALL a month, treat their patients with aggressive chemotherapy because there is a consensus that young children can better cope with the treatment their heart, liver, and lungs are better able to repair themselves after exposure to the toxic cancer-fighting drugs, and they have better psychological support systems to deal with their situation.
Adult oncologists, on the other hand, proceed with more caution, believing that the older body has less ability to heal itself and that adults are not as psychologically well-adapted for the hardships of intensive chemotherapy. In addition, the smaller number of young and mature adult ALL patients means that fewer studies and clinical trials have been done on adolescents and adults with the disease, so less information is available.
For their study, Dr. Ram and his fellow researchers conducted a systematic review of 11 comparative studies comparing the outcomes of 2,489 individuals aged 16-39. They completed an analysis to determine how the young adult regime compared to the pediatric treatment for this age group. They discovered that at three years, mortality was significantly lower when the patient was treated with the pediatric regime than with the adult chemotherapy/transplant combination, with a remission rate closer to that in children. Relapse rates were also significantly lower.
"The long-term survival of these young adults increased significantly when following the pediatric treatment," concludes Dr. Ram. The results disproved the assumption that with the more aggressive chemotherapy, young adult patients would have higher toxicity rates. "There was a worry that the patients might suffer or even die from the toxicity of the treatment, but toxicity rates remained the same. With the pediatric treatment, patients were more frequently in remission and had prolonged survival without bone marrow transplantation which itself is hard on the body."
More trials needed
Though the comparative studies have pointed researchers in the right direction, Dr. Ram says that this study is limited by a lack of randomized controlled trials, which could give more insight into whether the pediatric regime should be adopted as standard for young adult patients.
Still, the results are persuasive, leading to the conclusion that patients in this age group can be treated as pediatric patients in terms of the level of chemotherapy they can handle. "For a 16-20 year old, I would push them towards a pediatric regime," Dr. Ram says.
Provided by Tel Aviv University
- Leukemia deadlier for teens, young adults than younger kids: study Jun 02, 2012 | not rated yet | 0
- Cancer study finds adolescents don't get same access to latest treatments as younger patients Jan 15, 2008 | not rated yet | 0
- Survival rates for pediatric bone marrow transplants top in nation Jan 26, 2012 | not rated yet | 0
- Chemotherapy proves life-saving for some leukemia patients who fail induction therapy Apr 11, 2012 | not rated yet | 0
- Intensive chemotherapy can dramatically boost survival of older teenage leukemia patients Dec 20, 2010 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Why is zone 1 in liver more prone to ischemic injury?
8 hours ago Hi, Is it because around central vein, there is only deoxygenated blood from the vein where as in the periphery there is hepatic artery. Also why...
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013 As title suggest. Thanks :smile:
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013 Hello everyone, Ok Stomach's normal epithelium is simple columnar, now in intestinal type of adenocarcinoma of stomach it undergoes "intestinal...
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
- More from Physics Forums - Medical Sciences
More news stories
Treating pediatric leukemia patients with a liposomal formulation of anthracycline-based chemotherapy at a more intense-than-standard dose during initial treatment may result in high survival rates without causing any added ...
Cancer 19 minutes ago | not rated yet | 0
Scientists have uncovered a survival mechanism that occurs in breast cells that have just turned premalignant-cells on the cusp between normalcy and cancers-which may lead to new methods of stopping tumors.
Cancer 29 minutes ago | not rated yet | 0 |
Frequent heartburn was positively associated with cancers of the throat and vocal cord among nonsmokers and nondrinkers, and the use of antacids, but not prescription medications, had a protective effect, according to data ...
Cancer 56 minutes ago | not rated yet | 0
Aggressive forms of bladder cancer involve the protein PODXL – a discovery that could hold the key to improved treatment, according to researchers at Lund University, Uppsala University and KTH in Sweden.
Cancer 3 hours ago | 5 / 5 (1) | 0
A brief visual task can predict IQ, according to a new study. This surprisingly simple exercise measures the brain's unconscious ability to filter out visual movement. The study shows that individuals whose ...
27 minutes ago | 5 / 5 (1) | 0 |
A study by researchers at Henry Ford Hospital found "substantial evidence" that a regenerative process involving damaged nerve fibers in the spinal cord could hold the key to better functional recovery by most stroke victims.
39 minutes ago | not rated yet | 0 |
As the human body fine-tunes its neurological wiring, nerve cells often must fix a faulty connection by amputating an axon—the "business end" of the neuron that sends electrical impulses to tissues or other ...
38 minutes ago | 5 / 5 (1) | 0 |
Gaucher disease causes debilitating and sometimes fatal neurodegeneration in early childhood. Recent studies have uncovered a link between the mutations responsible for Gaucher disease and an increased risk ...
14 minutes ago | not rated yet | 0 |
Nervous about that upcoming job interview? You might want to take steps to reduce your jitters, especially if you are a man.
1 hour ago | not rated yet | 0